Related Experiment Video
Updated: Sep 26, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Long-term Antiretroviral Therapy and Anogenital Cancer Risk
Maanasa Mendu1,2, Taolo Ndloedibe1, Memory Bvochora-Nsingo3
1Botswana Harvard Health Partnership, Gaborone, Botswana.
Background:
People with human immunodeficiency virus (HIV) (PWH) experience substantially increased risk of anogenital cancer. Whether long-term antiretroviral therapy (ART) reduces anogenital cancer risk is unknown.
Methods:
A target trial emulation using a case-cohort design among Botswana adults aged 30-65, sampled via a probability-based household survey across 30 communities. Cases of cervical, vulvar, anal, and penile cancer were prospectively ascertained at the country's principal treatment centers. We estimated the marginal relative risk (RR) of incident anogenital cancer by ART duration, compared with adults without HIV, using g-computation from weighted models that accounted for shared determinants of human papillomavirus, and HIV infection, access to cancer care, and ART duration.
Results:
14 312 participants were enrolled (42% PWH), including 1045 (79% PWH) with incident anogenital cancer-792 cervical, 106 vulvar, 80 anal, and 67 penile cancers. Compared with people without HIV, the marginal RR (95% CI) of anogenital cancer increased with longer durations of ART (P = .001) (no ART: 4.6; 4.3-5.0; <5 years: 4.0; 3.7-4.3; 5-9 years: 4.6; 4.2-5.0; ≥10 years: 7.4; 6.8-8.1). Individuals receiving ART for ≥10 years had the highest RR for each cancer evaluated: cervix, 4.4 (4.0 to 4.8); vulva, 36 (22-57); anus, 15 (11-20); and penis, 102 (42-250). Prior advanced HIV disease was associated with increased risk but this effect diminished on ART and contributed relatively little to overall risk.
Conclusions:
Long-term utilization of ART was not associated with a reduction in anogenital cancer risk. Improved prevention strategies are needed for PWH.
Related Concept Videos
Retrovirus Life Cycles
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Amebiasis
Genital Herpes
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
